lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line

TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway

(2017) Jinkai Xu et al.   ONCOLOGY REPORTS

Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma

(2017) Cristina-Sorina Cătană et al.   Oncotarget

miRNA-106a directly targeting RARB associates with the expression of Na+/I− symporter in thyroid cancer by regulating MAPK signaling pathway

(2016) Chen-Tian Shen et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a

(2016) Chun-Chun Ma et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge

(2015) Liang Deng et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma

(2015) Zheng Zhang et al.   Molecular Cancer

Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p

(2015) M-Z Ma et al.   Cell Death & Disease

MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma

(2015) Lin Wang et al.   Oncotarget

Thyroid cancer mortality and incidence: A global overview

(2014) Carlo La Vecchia et al.   INTERNATIONAL JOURNAL OF CANCER

miR-143 inhibits cell proliferation by targeting autophagy-related 2B in non-small cell lung cancer H1299 cells

(2014) JIALI WEI et al.   Molecular Medicine Reports

VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2

(2014) D Zhao et al.   ONCOGENE

C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion

(2014) Xiaolu He et al.   TUMOR BIOLOGY

Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients

(2014) CHAOFENG DING et al.   Oncology Letters

A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer

(2013) Xuefei Shi et al.   MOLECULAR CARCINOGENESIS

Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression

(2012) A Pagliuca et al.   ONCOGENE

Characterization of a carcinogenesis-associated long non-coding RNA

(2012) Feng Yang et al.   RNA Biology

Colon cancer associated transcript-1: A novel RNA expressed in malignant and pre-malignant human tissues

(2011) Aviram Nissan et al.   INTERNATIONAL JOURNAL OF CANCER

miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS

(2011) Bin Xu et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Thyroid Cancer Epidemiology and Prognostic Variables

(2010) J.A. Sipos et al.   CLINICAL ONCOLOGY

Demethylation ofTMS1Gene Sensitizes Thyroid Cancer Cells to TRAIL-Induced Apoptosis

(2010) Abdul K. Siraj et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

New clinical features of thyroid cancer in eastern China

(2010) J. Xiang et al.   Journal of Visceral Surgery

MicroRNAs in Cancer

(2009) Ramiro Garzon et al.   Annual Review of Medicine

Role of miR-143 targeting KRAS in colorectal tumorigenesis

(2009) X Chen et al.   ONCOGENE

MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility

(2008) Marina N. Nikiforova et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

MicroRNomics: a newly emerging approach for disease biology

(2008) Chunxiang Zhang   PHYSIOLOGICAL GENOMICS